Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Mark Bernard Leick, M.D.

Concepts (129)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Immunotherapy, Adoptive25202415122.550 Why?
Receptors, Antigen, T-Cell7202425680.940 Why?
Hematologic Neoplasms5202419070.920 Why?
Graft vs Host Disease3202230490.880 Why?
Pulmonary Alveolar Proteinosis12022410.790 Why?
Hematopoietic Stem Cell Transplantation6202457170.690 Why?
Hematologic Diseases220234980.670 Why?
Communication Barriers120204190.550 Why?
Professional-Family Relations120205010.530 Why?
Leukemia, Myeloid, Acute3202236260.500 Why?
Lymphoma, B-Cell120209450.440 Why?
fms-Like Tyrosine Kinase 3120174940.430 Why?
T-Lymphocytes182024102660.430 Why?
Neurotoxicity Syndromes220233020.300 Why?
Lymphohistiocytosis, Hemophagocytic220232710.290 Why?
Physician-Patient Relations1202032690.280 Why?
Glioblastoma4202434640.260 Why?
Communication1202039050.260 Why?
Molecular Targeted Therapy1201728300.250 Why?
Bone Marrow Transplantation2202427090.230 Why?
Interleukin-7120231460.210 Why?
Transplantation Conditioning2202016010.210 Why?
B-Cell Maturation Antigen120241490.210 Why?
GPI-Linked Proteins120244720.200 Why?
Central Nervous System Neoplasms220229280.200 Why?
Lymphoma2202218980.190 Why?
Xenograft Model Antitumor Assays3202436120.180 Why?
Protein Kinase Inhibitors1201757040.180 Why?
Endopeptidases120247640.170 Why?
Interleukin 1 Receptor Antagonist Protein120222990.170 Why?
Hospital Departments120201350.170 Why?
Translating120201440.160 Why?
Antineoplastic Agents22023136770.160 Why?
Pancytopenia120191020.160 Why?
Humans3820247681710.150 Why?
Cyclophosphamide2202322270.150 Why?
Proto-Oncogene Proteins c-bcl-21202414060.140 Why?
Transduction, Genetic120208990.140 Why?
Lentivirus120205180.140 Why?
Lymphoma, T-Cell, Cutaneous120192100.140 Why?
Neoplasms32023223710.140 Why?
Antigen-Presenting Cells120209600.140 Why?
Telephone120206300.140 Why?
Antibodies, Bispecific120192040.130 Why?
Tandem Repeat Sequences120171830.130 Why?
Antigens, Neoplasm2202419960.130 Why?
Multiple Myeloma2202451960.130 Why?
Sulfonamides1202419820.120 Why?
Ubiquitin-Protein Ligases1202319010.110 Why?
Lymphoma, Non-Hodgkin1202113750.110 Why?
Gene Expression Regulation, Leukemic120176580.110 Why?
Autoantibodies1202221210.110 Why?
Drug Approval120208210.110 Why?
Flow Cytometry1202459020.110 Why?
Biological Products120229470.110 Why?
Lymphoma, Large B-Cell, Diffuse1202214370.100 Why?
United States Food and Drug Administration1202016730.100 Why?
Organoplatinum Compounds120124080.090 Why?
Hodgkin Disease1201913840.090 Why?
Tumor Microenvironment1202439480.090 Why?
Antigens, CD19220224460.080 Why?
Apoptosis1202495270.070 Why?
Intensive Care Units1202038000.070 Why?
Cell Line, Tumor42024171420.070 Why?
Pancreatic Neoplasms1202454420.070 Why?
Skin1201945050.060 Why?
Antibodies, Monoclonal1202392620.060 Why?
Neoplasm Staging12020112440.060 Why?
Combined Modality Therapy1201785420.060 Why?
Antigens, CD712024290.060 Why?
Antineoplastic Combined Chemotherapy Protocols22017118780.060 Why?
Disease Progression12020136680.050 Why?
Cytokines3202374520.050 Why?
bcl-X Protein120244120.050 Why?
Bone Marrow2202429350.050 Why?
Drug Resistance, Neoplasm1201753410.050 Why?
France120234970.050 Why?
Clinical Trials as Topic1201780520.050 Why?
Antibodies, Viral2202232140.040 Why?
Transgenes1202410160.040 Why?
Adult720242236460.040 Why?
Ubiquitination1202310090.040 Why?
Macrophage Activation120225570.040 Why?
Serine Endopeptidases1202410270.040 Why?
Mice52024820490.040 Why?
Codon, Nonsense120192870.040 Why?
Brain Neoplasms1201991180.040 Why?
Liver Neoplasms1201243630.030 Why?
Cell Death1202216800.030 Why?
United States22023730390.030 Why?
Transforming Growth Factor beta1202320040.030 Why?
Leukocytes, Mononuclear1202218540.030 Why?
Exanthema120195030.030 Why?
Fatal Outcome1201918360.030 Why?
Tissue Donors1202423810.030 Why?
Neoplasm Recurrence, Local2202494190.030 Why?
Child22023809170.030 Why?
Neoplasms, Experimental1201912300.030 Why?
Treatment Outcome22019653790.030 Why?
Signal Transduction12017236480.030 Why?
Antigens, CD1202440350.030 Why?
Retrospective Studies22019817600.030 Why?
Animals520241692850.030 Why?
Interferon-gamma1202231610.030 Why?
Carcinoma, Pancreatic Ductal1202417560.030 Why?
Middle Aged620242234870.030 Why?
Infusions, Intra-Arterial120122200.030 Why?
Mutation12017302370.030 Why?
Fever1201916140.020 Why?
Recurrence1202485090.020 Why?
Proto-Oncogene Proteins1202445280.020 Why?
Peptide Fragments1202451510.020 Why?
Hepatic Artery120122320.020 Why?
Aged520241715020.020 Why?
CD8-Positive T-Lymphocytes1202446480.020 Why?
Vaccination1202234370.020 Why?
Male620243647310.020 Why?
Biopsy1201967920.020 Why?
Membrane Proteins1202478760.020 Why?
Adenocarcinoma1202463950.020 Why?
Cognition1202370730.020 Why?
Female520243971870.020 Why?
Incidence12023215380.020 Why?
Diagnosis, Differential12019130130.010 Why?
Cell Differentiation12019116770.010 Why?
Risk Factors12024749440.010 Why?
Young Adult12019600660.010 Why?
Adolescent12019891690.010 Why?
Aged, 80 and over12012596260.000 Why?
Leick's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (129)
Explore
_
Co-Authors (74)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.